ロード中...
Heparanase inhibitors restrain mesothelioma
Malignant mesothelioma is a highly aggressive form of cancer with poor prognosis due to lack of markers for early diagnosis and resistance to conventional therapies. Heparanase, the sole heparan sulfate (HS) degrading endoglycosidase, regulates multiple biological activities that enhance tumor growt...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6305150/ https://ncbi.nlm.nih.gov/pubmed/30627323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26243 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|